Biolinq
Patrick McBride has a diverse work experience in the software engineering field. Patrick currently works as the Associate Director of Software Engineering at Biolinq since March 2023. Prior to that, they were the Founder of Gulwynd Inc from September 2021 to March 2023. McBride also has experience working at Dexcom, where they served as a Product Manager from April 2020 to September 2021 and as a Staff Software Engineer from March 2016 to April 2020. At McBride Applications (working name), their own software start-up, they took on the role of Founder from August 2014 to March 2016. McBride also worked at Sony Computer Entertainment America LLC as a Staff Application Engineer from March 2006 to July 2014 and at AboveHealth as a Sr. Software Engineer from 2000 to 2006. Additionally, they worked at Infogation as a Software Engineer from January 1999 to May 2000 and at Radiation Oncology Computer Systems as a Software Engineer from 1997 to 1999.
Patrick McBride earned a Bachelor of Science (BS) degree in Physics from the University of California, Santa Cruz, graduating in 1995. Patrick later pursued a Master of Business Administration (M.B.A.) degree at the University of California, San Diego - Rady School of Management, which they completed from 2016 to 2018. Prior to their M.B.A., McBride also attended the University of California, Santa Cruz for their undergraduate studies in Physics, although the specific duration is not provided.
Biolinq
2 followers
Biolinq develops a wearable biosensor platform that is capable of measuring blood level information. Under the leadership of Jared Tangney and Josh Windmiller, Biolinq is redefining how biomedical innovations can be imagined and commercialized. While conducting his post-doctoral research at the University of California, San Diego in the laboratoryfor NanoBioElectronics, Josh saw the potential to bring nanotechnology to the medical world. Combining forces with Jared, a Ph.D. in Biomedical Engineering, the two saw the opportunity to bring their minimally-invasive technology to the diabetes space. Finally, people with diabetes will have a better CGM experience that is not only more affordable but also pain-free.